NSG 533 Exam 2 Questions and Answers (250+ Genetics, Genomics, Hepatitis, NAFLD & Cancer Biology Q&A) | Mendelian Inheritance, Genetic Disorders, Hepatitis A–D, Nonalcoholic Fatty Liver Disease & Oncology Concepts | NSG 533 Advanced Pathophysiology 2026

This comprehensive NSG 533 Exam 2 Questions and Answers study guide contains more than 250 exam-style questions, answers, and detailed rationales covering medical genetics, genomics, inheritance patterns, genetic disorders, chromosomal abnormalities, hepatitis pathophysiology, liver disease, nonalcoholic fatty liver disease (NAFLD), cancer biology, tumor genetics, and advanced pathophysiology concepts. The material is specifically designed to help nursing students master high-yield concepts frequently tested in NSG 533 examinations, advanced pathophysiology courses, graduate nursing programs, nurse practitioner curricula, and board-style assessments. The guide provides an extensive review of genetics and genomics, including genes, genomes, genetic variation, Mendelian inheritance patterns, autosomal dominant disorders, autosomal recessive disorders, X-linked inheritance, mitochondrial inheritance, genomic imprinting, uniparental disomy, chromosomal mutations, penetrance, anticipation, mosaicism, genotype-phenotype relationships, and epigenetics. Students learn to distinguish between major inheritance patterns while examining clinically significant genetic conditions such as cystic fibrosis, sickle cell disease, Tay-Sachs disease, Duchenne muscular dystrophy, Marfan syndrome, Huntington disease, Fragile X syndrome, Rett syndrome, hereditary hemochromatosis, and BRCA-associated cancers. Advanced concepts such as CRISPR gene editing, heterozygote advantage, pharmacogenetics, predictive testing, prenatal testing, and newborn genetic screening are also explored in detail. A major portion of the study material focuses on viral hepatitis and liver disease pathophysiology. Students review Hepatitis A (HAV), Hepatitis B (HBV), Hepatitis C (HCV), and Hepatitis D (HDV), including transmission routes, incubation periods, clinical manifestations, diagnostic laboratory markers, serologic interpretation, treatment strategies, vaccination recommendations, disease prevention, and long-term complications. Content includes interpretation of HBsAg, HBsAb, HBcAb, HCV antibody testing, PCR viral load analysis, fibrosis assessment, chronic hepatitis management, cirrhosis development, hepatocellular carcinoma risk, and current antiviral therapies. The material emphasizes clinical reasoning skills necessary for identifying, diagnosing, and managing infectious liver diseases in advanced nursing practice. The guide also delivers comprehensive coverage of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), including epidemiology, disease progression, obesity-related pathogenesis, insulin resistance, metabolic syndrome, fibrosis development, diagnostic imaging, liver biopsy interpretation, elastography, fibrosis scoring systems, pediatric NAFLD, and evidence-based treatment strategies. Students examine the relationship between obesity, type 2 diabetes mellitus, dyslipidemia, metabolic syndrome, and progressive liver injury while reviewing pharmacologic and lifestyle interventions used to reduce fibrosis and prevent progression to cirrhosis and hepatocellular carcinoma. Additional content focuses on cancer biology and molecular oncology, including tumor suppressor genes, proto-oncogenes, oncogenes, genomic instability, metastasis, invasion, anaplasia, retinoblastoma, TP53 mutations, immune evasion mechanisms, carcinoma in situ, cancer metabolism, hereditary cancer syndromes, and the molecular basis of tumor development. Students gain a deeper understanding of cellular transformation, cancer progression, genetic susceptibility, and pathophysiologic mechanisms that drive malignant disease. The question-and-answer format promotes active recall, critical thinking, and exam readiness while reinforcing concepts essential for advanced nursing education and clinical practice. Academic References: McCance, K. L., & Huether, S. E. (2024). Pathophysiology: The Biologic Basis for Disease in Adults and Children (10th Edition). Elsevier. Copstead, L. C., & Banasik, J. L. (2024). Pathophysiology (7th Edition). Elsevier. Lewis, S. M., Bucher, L., Heitkemper, M. M., Harding, M. M., Kwong, J., & Roberts, D. (2024). Medical-Surgical Nursing: Assessment and Management of Clinical Problems (12th Edition). Elsevier. Kumar, V., Abbas, A. K., & Aster, J. C. (2025). Robbins & Cotran Pathologic Basis of Disease (11th Edition). Elsevier. Kliegman, R. M., St. Geme, J. W., Blum, N. J., Shah, S. S., Tasker, R. C., & Wilson, K. M. (2024). Nelson Textbook of Pediatrics (22nd Edition). Elsevier. National Human Genome Research Institute (NHGRI). Genetics and Genomics Educational Resources. American Association for the Study of Liver Diseases (AASLD). Hepatitis and NAFLD Clinical Practice Guidelines. Relevant Students: This resource is ideal for NSG 533 students, Advanced Pathophysiology students, Family Nurse Practitioner (FNP) students, Adult-Gerontology Nurse Practitioner (AGNP) students, Doctor of Nursing Practice (DNP) students, Master of Science in Nursing (MSN) students, Advanced Practice Registered Nurse (APRN) students, Graduate Nursing students, Medical-Surgical Nursing students, Genetics students, Genomics students, Hepatology students, Oncology Nursing students, Nurse Practitioner certification candidates, Pathophysiology examination candidates, Public Health students, Healthcare professionals, and nursing students preparing for advanced nursing examinations, board certification assessments, and clinical practice. Keywords NSG 533, NSG 533 Exam 2, advanced pathophysiology, genetics, genomics, gene expression, genome, Mendelian inheritance, autosomal dominant, autosomal recessive, X linked dominant, X linked recessive, mitochondrial inheritance, genomic imprinting, uniparental disomy, chromosomal mutations, deletion mutation, duplication mutation, inversion mutation, translocation mutation, substitution mutation, penetrance, anticipation, mosaicism, genotype, phenotype, epigenetics, CRISPR, gene editing, pharmacogenetics, heterozygote advantage, prenatal testing, newborn screening, cystic fibrosis, CFTR gene, sickle cell disease, HBB gene, Tay Sachs disease, HEXA gene, Duchenne muscular dystrophy, DMD gene, Marfan syndrome, Huntington disease, Fragile X syndrome, Rett syndrome, hereditary hemochromatosis, BRCA1, BRCA2, hepatitis A, HAV, hepatitis B, HBV, hepatitis C, HCV, hepatitis D, HDV, liver disease, cirrhosis, hepatocellular carcinoma, HCC, viral hepatitis, liver fibrosis, HBsAg, HBsAb, HBcAb, HCV antibody, HCV PCR, elastography, NAFLD, nonalcoholic fatty liver disease, NASH, nonalcoholic steatohepatitis, metabolic syndrome, obesity, insulin resistance, type 2 diabetes, liver biopsy, fibrosis score, hepatology, oncology, cancer biology, tumor suppressor genes, oncogenes, proto oncogenes, retinoblastoma, RB1, TP53, genomic instability, metastasis, invasion, anaplasia, carcinoma in situ, cancer pathophysiology, nursing exam review, graduate nursing exam preparation